Project Number ADDF-12 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2020 View Full Project Details for Digitally-enhanced personalized medicine: Accurate selection of subjective cognitive decline and measuring progression of mild cognitive impairment Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 4. Personal assessments (using wearable and mobile technology) Researcher and Organization Principal Investigator Tarnanas, Ioannis Principal Investigator First Name Ioannis Principal Investigator Last Name Tarnanas Awardee Organization Altoida, Inc. Awardee State District of Columbia Contact PI Country United States Project Detail Funding Opportunity Announcement ADDF-Neuroimaging and CSF Biomarkers Program FY Overall Cost $498,335 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management
